Russia Completes Preparations for Clinical Trials of COVID-19 Vaccine

Strategic Insights -

The Russian Ministry of Defense has completed preparations for the start of clinical trials of a Russian vaccine against COVID-19 infection. In the coming days, the first group of volunteers will be vaccinated to study the safety and tolerability of the vaccine components. This group will undergo a two-week isolation period, after which they will be monitored for any adverse effects. The health of all volunteers, including military and civilian participants, is currently good, and they continue to be under close supervision by military physicians.

Key Takeaways:

  • The Russian vaccine trials will be conducted jointly by the Ministry of Defense and the National Research Centre of Epidemiology and Microbiology.
  • The first group of volunteers, consisting of military and civilian participants, will undergo vaccination to study the safety and tolerability of the vaccine components.
  • The volunteers will be isolated for two weeks after vaccination and will be monitored for any adverse effects.
  • The health of all volunteers is currently good, and they are under close supervision by military physicians.
  • The vaccine trials are being carried out on a voluntary basis, with participants drawn from various divisions of troops NBC protection and medical institutions of the Russian defense Ministry.
  • The clinical studies are expected to be completed by the end of July.
  • The vaccine has been tested for toxicity, safety, immunogenicity, and protective efficacy on large and small animals at the 48 Central Research Institute of the Ministry of Defense.

Statistics:

  • The first group of volunteers will undergo vaccination to study the safety and tolerability of the vaccine components.
  • The volunteers will be isolated for two weeks after vaccination.
  • The vaccine trials are expected to be completed by the end of July.
  • The Russian vaccine trials will involve both military and civilian participants.
  • The vaccine has been tested on large and small animals at the 48 Central Research Institute of the Ministry of Defense.

Sources:

  • The Russian Ministry of Defense (no date cited)
  • The Ministry of Health of Russia (no date cited)
  • National Research Centre of Epidemiology and Microbiology them. N. F.Gamalei (no date cited)
  • A meeting via videoconference between Russian President Vladimir Putin and Minister of Defense General Sergei Shoigu on May 26 (cited as a meeting on May 26, source not specified)